Clear Street’s Cartesian Growth Corp II RENE Stock Holding History

Clear Street’s Portfolio RENE Stock Details RENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,298	Closed	-$74.7K	–	710
2025 Q1	$74.7K	Buy	6,298 +2,481	+65%	+$29.2K	﹤0.01%	149
2024 Q4	$44.5K	Buy	3,817 +317	+9%	+$3.67K	﹤0.01%	191
2024 Q3	$40.1K	Sell	3,500 -35,263	-91%	-$401K	﹤0.01%	228
2024 Q2	$437K	Buy	+38,763	New	+$435K	﹤0.01%	110
2023 Q4	–	Sell	-56	Closed	-$608	–	921
2023 Q3	$608	Sell	56 -9,504	-99%	-$102K	﹤0.01%	937
2023 Q2	$102K	Buy	9,560 +9,449	+8,513%	+$99.9K	﹤0.01%	345
2023 Q1	$1.16K	Sell	111 -368	-77%	-$3.82K	﹤0.01%	934
2022 Q4	$5K	Buy	+479	New	+$4.86K	﹤0.01%	655

Other funds holding RENE

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return

Clear Street's RENE Position: Q2 2025 in Review

Clear Street sold out of Cartesian Growth Corp II (RENE) in Q2 2025, closing a stake of 6,298 shares — an estimated $74.7K sold.

Clear Street first reported a position in RENE in Q4 2022 and held it in 8 quarters. The position peaked at $437K in Q2 2024. 4 funds tracked by Wall St. Rank hold RENE as of Q2 2025.

Clear Street reported no remaining Cartesian Growth Corp II position as of Q2 2025 after selling out during the quarter.
Clear Street sold 6,298 Cartesian Growth Corp II shares in Q2 2025, an estimated $74.7K.
Clear Street first reported a position in Cartesian Growth Corp II in Q4 2022 and held it in 8 quarters.
Clear Street's Cartesian Growth Corp II position peaked at $437K in Q2 2024.
4 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q2 2025.

Based on Clear Street's 13F filing for Q2 2025, filed 13 Aug 2025.